Keyword: Biosimilars

News

Sandoz Acquires Ophthalmology Franchise from Coherus

08.03.2024 -

In a move to expand its ophthalmic platform, Sandoz, the former generics and biosimilars arm of Swiss drugmaker Novartis, has completed the acquisition of Coherus...

News

Gedeon Richter Becomes Strategic Investor of Formycon

30.01.2024 -

Hungary-headquartered specialty pharmaceutical company Gedeon Richter becomes a strategic investor of German biosimilars company Formycon via cash capital increase of 9...

Chemistry & Life Sciences

The Success Story of Biosimilars

13.09.2023 -

With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...

News

CVS Health Launches Biosimilars Subsidiary Cordavis

29.08.2023 -

US drugstore chain CVS Health has launched Cordavis, a wholly owned subsidiary that will collaborate with manufacturers to commercialize and co-produce biosimilar...

News

Samsung Biologics and Pfizer in Biosimilars Pact

13.06.2023 -

South Korean CDMO Samsung Biologics has entered into a long-term manufacturing partnership with major drugmaker Pfizer.

News

Novartis Definitely Plans to Spin off Sandoz

29.08.2022 -

Novartis has finally confirmed definite plans to spin off its generic drugs arm Sandoz.

News

New EU Generics Rules to Boost Competitiveness

26.02.2019 - The EU is adopting new rules that should make it easier for producers of generic drugs and biosimilars in member states to compete on the global market. On Feb. 20, the states...

Markets & Companies

MENA Pharmaceutical Market

29.11.2018 - The MENA (Middle East and North Africa) region is a largely untapped, yet potentially hugely fruitful part of the world for the pharmaceutical industry, both as a sales region and...